BACKGROUND: Actinic cheilitis, a common disease caused by chronic solar exposure and tobacco use, is considered a premalignant lesion with potential to develop into squamous cell carcinoma. Some of the available treatments are invasive, have unaesthetic results and require multiple sessions. OBJECTIVE: To assess the efficacy of a therapy and its cosmetic results. METHODS: In this uncontrolled clinical trial a single photodynamic therapy (PDT) session using 16% methyl-aminolevulinate was performed on actinic cheilitis of the lower lip. A standardized questionnaire was applied in order to assess the clinical improvement from the patients' point of view and the satisfaction with the treatment. Anatomopathological evaluation was performed befor...
Actinic cheilitis is an oral potentially malignant disorder caused by UV radiation leading to damage...
INTRODUCTION: Since actinic keratoses (AKs) often appear in areas with field cancerization, photodyn...
Photodynamic therapy (PDT) with methyl aminolevulinate (MAL) is approved in Europe for the treatment...
BACKGROUND: Actinic cheilitis, a common disease caused by chronic solar exposure and tobacco use, is...
BACKGROUND: Actinic cheilitis, a common disease caused by chronic solar exposure and tobacco use, is...
Introduction Actinic cheilitis (AC) is the biologic precursor of invasive squamous cell carcinoma (S...
INTRODUÇÃO: A queilite actínica é uma neoplasia intra-eptelial do lábio cujas células apresentam alt...
Aktinik keilit invaziv skuamöz hücreli karsinomaya dönüşebilen prekanseröz bir lezyondur. Fotodinami...
Actinic cheilitis (AC) is a chronic inflammation of the lip considered an oral, potentially malignan...
Actinic cheilitis is a premalignant condition that may evolve to squamous cell carcinoma. A consensu...
cheilitis (AC) is a chronic inflammation that affects more frequently to the lower lip and is consid...
Objective: the aim of the present study was to evaluate the clinical and histopathological efficacy ...
Background and objective: Photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) and intense pu...
Photodynamic therapy (PDT) with light emitting diode (LED) illumination is a frequently used treatme...
Actinic keratosis (AK) is the most common in situ cancerous skin lesion. Compared with other approve...
Actinic cheilitis is an oral potentially malignant disorder caused by UV radiation leading to damage...
INTRODUCTION: Since actinic keratoses (AKs) often appear in areas with field cancerization, photodyn...
Photodynamic therapy (PDT) with methyl aminolevulinate (MAL) is approved in Europe for the treatment...
BACKGROUND: Actinic cheilitis, a common disease caused by chronic solar exposure and tobacco use, is...
BACKGROUND: Actinic cheilitis, a common disease caused by chronic solar exposure and tobacco use, is...
Introduction Actinic cheilitis (AC) is the biologic precursor of invasive squamous cell carcinoma (S...
INTRODUÇÃO: A queilite actínica é uma neoplasia intra-eptelial do lábio cujas células apresentam alt...
Aktinik keilit invaziv skuamöz hücreli karsinomaya dönüşebilen prekanseröz bir lezyondur. Fotodinami...
Actinic cheilitis (AC) is a chronic inflammation of the lip considered an oral, potentially malignan...
Actinic cheilitis is a premalignant condition that may evolve to squamous cell carcinoma. A consensu...
cheilitis (AC) is a chronic inflammation that affects more frequently to the lower lip and is consid...
Objective: the aim of the present study was to evaluate the clinical and histopathological efficacy ...
Background and objective: Photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) and intense pu...
Photodynamic therapy (PDT) with light emitting diode (LED) illumination is a frequently used treatme...
Actinic keratosis (AK) is the most common in situ cancerous skin lesion. Compared with other approve...
Actinic cheilitis is an oral potentially malignant disorder caused by UV radiation leading to damage...
INTRODUCTION: Since actinic keratoses (AKs) often appear in areas with field cancerization, photodyn...
Photodynamic therapy (PDT) with methyl aminolevulinate (MAL) is approved in Europe for the treatment...